Oprah Leaves WeightWatchers Amid Weight Loss Drug Craze

Stepping Down

Oprah Winfrey is stepping down from the WeightWatchers (WW) board of directors.

Her decision to step back from WeightWatchers came a year earlier than her contract stated, though the company maintained there was no disagreement between the two parties. She plans to donate all of her stock to the National Museum of African American History and Culture.

Oprah spent nearly a decade being involved with the weight-loss company, which is facing fierce competition from weight-loss drugs like Novo Nordisk’s (NOVO) Ozempic and Wegovy. Oprah said in December that she uses a weight-loss drug.

WW vs Novo

Instead of trying to fight the popularity of these drugs, WeightWatchers has attempted to adapt its model in response. The company recently announced multiple initiatives, including a membership plan that connects members already using the drugs with doctors who can prescribe them.

But that doesn’t seem to have been quite enough for investors. WeightWatchers’ stock has been in freefall since the start of 2024, dropping more than 60% in the past two months.

Looking for more stories like this? Check out On the Money — SoFi’s one-stop-shop for news, trends, and tips!

Check it out

Please understand that this information provided is general in nature and shouldn’t be construed as a recommendation or solicitation of any products offered by SoFi’s affiliates and subsidiaries. In addition, this information is by no means meant to provide investment or financial advice, nor is it intended to serve as the basis for any investment decision or recommendation to buy or sell any asset. Keep in mind that investing involves risk, and past performance of an asset never guarantees future results or returns. It’s important for investors to consider their specific financial needs, goals, and risk profile before making an investment decision.
The information and analysis provided through hyperlinks to third party websites, while believed to be accurate, cannot be guaranteed by SoFi. These links are provided for informational purposes and should not be viewed as an endorsement. No brands or products mentioned are affiliated with SoFi, nor do they endorse or sponsor this content.
Communication of SoFi Wealth LLC an SEC Registered Investment Advisor.
SoFi isn’t recommending and is not affiliated with the brands or companies displayed. Brands displayed neither endorse or sponsor this article. Third party trademarks and service marks referenced are property of their respective owners.
SOSS24030403